• / Free eNewsletters & Magazine
  • / My Account
Home>G-7

G-7

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  1. Salix and Pharming Announce FDA Approval of RUCONEST® for the Treatment of Acute Angioedema Attacks in Patients with Hereditary Angioedema (HAE)

    Salix and Pharming Announce FDA Approval of RUCONESTĀ® for the Treatment of Acute Angioedema Attacks in Patients with Hereditary Angioedema (HAE)

  2. European Unemployment Not Out of Woods

    Although joblessness in some developed economies has decreased in the last year, several European countries are still seeing double-digit unemployment rates.

  3. Recovery Gains Momentum, But Persistently Low Inflation Remains a Concern

    This article is for informational purposes only. This article is not intended to provide tax, legal, insurance or other investment advice. Unless otherwise specified, you are solely responsible for determining whether any investment, security or other product or service is appropriate for you based ...

12345
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.